| 1H-NMR | 108 |
| 2,4-dinitrophenylhydrazine | 679 |
| 2DNMR | 108 |
| 32 factorial design | 221 |
| 5-fluorouracil | 578 |
| Ab initio | 177 |
| Abl kinase | 49 |
| Absorption | 673 |
| Acebutolol HCl | 673 |
| Acetaminophen | 119 |
| Acetamiprid | 474 |
| AChE | 506 |
| Acidic dissociation constant | 177 |
| Activity | 81 |
| Adulteration | 56 |
| AgNPs | 599 |
| Alkaline phosphatase | 440 |
| Allergic contact dermatitis | 452 |
| Alloxan | 319 |
| Alpha-1 antitrypsin | 576 |
| Alpha-lactose | 249 |
| Amaryllidaceae alkaloids | 36 |
| Amidinobenzimidazole | 108 |
| Amidoxim | 108 |
| Amylase | 68 |
| Analgesic activity | 408 |
| Andersen cascade impactor | 20 |
| Angiogenesis | 424 |
| Anti-Alzheimer | 127 |
| Anti-inflammatory | 127 |
| Antibacterial activities | 565 |
| Antibiofilm | 667 |
| Anticancer | 127 |
| Anticancer effect | 492 |
| Anticholinesterase | 528 |
| Anticholinesterase activity | 36 |
| Antidepressant | 293 |
| Antiinflammatory | 599 |
| Antiinflammatory effect | 586 |
| Antimicrobia | 81 |
| Antimicrobial | 299, 511 |
| Antimicrobial activity | 500 |
| Antinociceptive effect | 586 |
| Antioxidant | 127, 197, 271, 299, 549, 599, 610, 626 |
| Antioxidants | 343 |
| Antiviral | 127 |
| Antler | 440 |
| Apiaceae | 197 |
| Apigel | 94 |
| Apoptosis | 49, 446 |
| Apoptosis | 49, 578 |
| AR42J pancreatic cell line | 474 |
| Aspergillus fumigatus | 280 |
| Attitudes | 242 |
| Aziziye | 211 |
| Bacillus strains | 511 |
| BALB/c mice | 412 |
| Bath salts | 235 |
| Beads | 542 |
| Benzimidazole | 626 |
| Bilayer floating tablets | 645 |
| Bioavailability | 203 |
| Biochemical estimation | 319 |
| Biogenic | 299 |
| Bisphenol A | 337 |
| Bisphenol A | 457 |
| Bisphenol F | 457 |
| Bisphenol S | 457 |
| Bisphenols | 457 |
| Blood | 172 |
| Boric acid | 177 |
| Buccal tablets | 388 |
| C-myc | 337 |
| C267A | 653 |
| Caffeine | 408 |
| Candida spp. | 667 |
| Capparis spinosa | 412 |
| Carbapenem-resistant Pseudomonas aeruginosa | 63 |
| Carboxymethylcellulose | 645 |
| Carrageenan | 329 |
| Cationic steroid antibiotic | 63 |
| CDK2 | 417 |
| Cecal ligation and puncture | 99 |
| Chitosan | 27 |
| Chorioallantoic membrane | 424 |
| CHRM1 | 653 |
| Cisplatin | 1 |
| Citral | 549 |
| Cleaning | 182 |
| Colistin | 63 |
| Collagen production | 271 |
| Colloidal drug carrier system | 43 |
| Colony formation | 578 |
| Combination | 578 |
| Common centaury herb | 593 |
| Compactibility | 249 |
| Compaction simulator | 249, 367 |
| Complementary medicine | 293 |
| Compressibility | 367 |
| Computer fluid dynamic | 20 |
| Contact TLC-bioautography | 254 |
| Copper | 412 |
| Corchorus olitorius | 265 |
| Correlation | 203, 319 |
| Correlation of solubilities | 228 |
| COVID-19 | 242, 357, 576 |
| COVID-19 treatment | 463 |
| COX-2 | 424 |
| Curcumin | 417 |
| Cyclophosphamide | 115 |
| Cystic fibrosis | 686 |
| Cytotoxic | 127 |
| Cytotoxicity | 1, 81, 343, 474 |
| Decalepis nervosa | 319 |
| Depression | 293 |
| Derivatization of NSAIDs | 465 |
| Deuterium-depleted water | 99 |
| DFT | 177 |
| Diagnosis | 381 |
| Dimethyl sulfoxide | 307 |
| Dipeptidyl peptidase-4 inhibitors | 68 |
| Dipyridamole | 182 |
| Discriminative dissolution method | 74 |
| Dissolution | 203 |
| DNA methylation | 337 |
| DNA methyltransferase | 631 |
| DoE | 148 |
| Domperidone | 74 |
| Dopamine hydrochloride | 679 |
| Doxorubicin | 280 |
| DPPH | 197 |
| Drug delivery | 645 |
| Drug release | 638 |
| Drug removal | 463 |
| Drug repositioning | 492 |
| Drug resistance | 565 |
| Elaeagnus angustifolia | 285 |
| Electrospun nanofibers | 638 |
| Emulgel | 285 |
| Enalapril maleate | 159 |
| Endocrine disruptor | 457 |
| Epigenetic | 631 |
| Erzurum | 211 |
| Ether linked | 81 |
| Ethnobotany | 211 |
| Ethoxyresorufin O-deethylase activity | 626 |
| Ethyl cellulose | 638 |
| Etoricoxib | 7 |
| EUCAST | 667 |
| Eudragit | 645 |
| Evaluation | 372 |
| Exercise | 172 |
| Experimental design | 359 |
| Extended Hildebrand solubility approach | 228 |
| Face mask | 357 |
| Factorial design | 388 |
| FAS system | 565 |
| Fast dispersible tablets (FDTs) | 74 |
| Fenofibric acid | 203 |
| Ferulic acid | 424 |
| Floating | 542 |
| Floating microspheres | 159 |
| FlowLac®100 | 367 |
| Fluconazole | 667 |
| Fluticasone propionate | 359 |
| Food additives | 659 |
| Forced swimming test | 293 |
| Fungal infection | 259 |
| Galanthus fosteri | 36 |
| Gallic acid | 148 |
| Gastric cancer | 578 |
| Gastroretentive system | 159 |
| GC analysis | 465 |
| GC-MS | 343 |
| Gene modulators | 686 |
| Gene therapy | 686 |
| Genetic diversity | 480 |
| Genotoxicity | 1, 115, 446, 474 |
| Glassy carbon electrode | 398 |
| Gluconolactone | 659 |
| Glucuronolactone | 659 |
| Glycerol monooleate | 307 |
| Glycyrrhetic acid | 49 |
| Guar gum | 7 |
| Gum acacia | 7 |
| Hallucinogen | 235 |
| Harmacophore modeling | 417 |
| Hematology | 412 |
| Herbal dietary supplements | 56 |
| Hibiscus sabdariffa | 190 |
| High-performance liquid chromatographic-ultraviolet detection | 56 |
| Hippocampus | 620 |
| Histone deacetylase | 631 |
| Hospital pharmacists | 242 |
| HPLC | 523, 528, 593, 610 |
| HPMC 6000 | 190 |
| HPMC K4M | 221 |
| HPTLC | 148 |
| Human cervix cancer cells | 1 |
| Human foreskin | 265 |
| HUVECs | 549 |
| Hydrazone derivatives | 500 |
| Hydrochlorothiazide | 523 |
| Hydrogen peroxide | 549 |
| Hydroxypropyl methylcellulose | 542 |
| Hyperacidic gastritis | 94 |
| Hypoxia | 555 |
| Imidacloprid | 506 |
| Imidazole | 81 |
| Imine | 626 |
| Immersion TLC- bioautography | 254 |
| Immune system | 452 |
| In vitro release | 259 |
| Indigofera barberi | 136 |
| Inhibitory effect | 190 |
| Interaction energy | 228 |
| Intestinal cells | 446 |
| Intestinal perfusion technique | 673 |
| Irbesartan | 523 |
| Isolation | 528 |
| ISSR | 480 |
| Itraconazole | 228 |
| Inflammation | 94 |
| Iota-carrageenan | 159 |
| Jatropha curcas L. latex | 271 |
| K562 cells | 49 |
| Knowledge | 242 |
| L-929 cell line | 506 |
| Levocetirizine dihydrochloride | 27 |
| Limnophila repens | 329 |
| Lipase | 68 |
| Lipid peroxidation | 626 |
| Liver | 412 |
| Log D | 535 |
| Log kw | 535 |
| Log P | 535 |
| LPO | 197 |
| Lysimachia | 528 |
| Malondialdehyde | 620 |
| MCF-7 | 280 |
| MDR Salmonella species | 511 |
| Medicinal plants | 211 |
| Meloxicam | 408 |
| Memory performance | 555 |
| Metabolites | 511 |
| Metformin | 141 |
| Method development | 182, 593 |
| Methylene blue | 381 |
| Microemulsion | 43, 259 |
| Micronucleus | 115 |
| MicroRNA | 452 |
| Microstructure | 307 |
| Mineralization | 440 |
| Minimum bactericidal concentrations | 63 |
| Minimum inhibitory concentrations | 63 |
| miRNA | 452 |
| Modified release tablets | 486 |
| Molecular docking | 417 |
| Moringa oleifera | 148 |
| Multi-walled carbon nanotubes | 398 |
| Naftifine | 43 |
| Nanoparticles | 299, 359, 412, 492, 599 |
| Naproxen sodium | 486 |
| Neem gum | 388 |
| Neurotoxicity | 235 |
| Nickel oxide nanoparticles | 446 |
| Nicorandil | 388 |
| Nigella sativa oil | 115 |
| Nitric oxide | 119 |
| Nitric oxide inhibition | 440 |
| NMDA receptor | 620 |
| Non-cultivated vegetables | 599 |
| Non-Fickian diffusion mechanism | 221 |
| Novel object recognition task | 555 |
| NRK-52E cells | 337 |
| NSAIDs | 465 |
| Oleic acid | 307 |
| Oral antidiabetics | 68 |
| Orally disintegrating tablets | 486 |
| Ornidazole | 81 |
| Oxidative damage | 474 |
| Oxidative stress | 446, 506, 549 |
| Oxidative stress-antioxidant parameters | 99 |
| P-glycoprotein | 673 |
| Pain | 119 |
| Palladium | 299 |
| Paracetamol | 136, 249 |
| Particle size distribution | 20 |
| PCR-RFLP | 653 |
| Pectin | 542 |
| Pendimethalin | 631 |
| Pentacyclic triterpenoid | 49 |
| Periodontitis | 94 |
| Pharmaceutical composition | 408 |
| Pharmaceutical dosage forms | 523 |
| Pharmaceuticals | 398 |
| Pharmacist | 357 |
| Pharmacokinetic | 463 |
| Phenolics | 610 |
| Physicochemical properties | 535 |
| Phytochemical screening | 329 |
| Phytochemicals | 319 |
| Piroxicam | 408, 535 |
| pKa | 535 |
| Plant extract | 610 |
| Platencimycin | 565 |
| Platencin | 565 |
| Platinum | 299 |
| Poloxamer | 372 |
| Polydisperse aerosols | 20 |
| Polymeric nanoparticle | 27 |
| Polyphenol | 432 |
| Polyurethane | 638 |
| Polyvinylpyrrolidone | 638 |
| Pravastatin | 221 |
| Prediction | 228 |
| Prenatal stress | 620 |
| Probiotic | 293 |
| Prodrug | 108 |
| Protocatechuic acid | 578 |
| Psychoactive | 235 |
| Pulsatile | 542 |
| Pycnogenol | 1 |
| Pyrazoline derivatives | 500 |
| Pyrophen | 280 |
| Quercetin | 148 |
| Radical scavenging | 136 |
| RAPD | 480 |
| Rassf1a | 337 |
| Rectal organoids | 686 |
| Red Sea | 127 |
| Rifampicin | 398 |
| Rosa damascena Mill essential oil | 99 |
| RP-HPLC | 141 |
| Rusa unicolor | 440 |
| Rutin | 148 |
| Safety | 432 |
| Salvia species | 480 |
| Schizophrenia | 653 |
| Scrophulariaceae | 586 |
| Seed of Spondias mombin | 343 |
| Sentinel lymph node | 381 |
| Sepsis | 99 |
| Serotonin | 119 |
| Seseli | 197 |
| Shrimp | 254 |
| Sildenafil | 56 |
| Silver nanoparticles | 511 |
| Silymarin | 136 |
| Skin | 452 |
| Small angle X-ray scattering | 307 |
| Soccer players | 172 |
| Sodium alginate | 159 |
| Solid dispersion | 372 |
| Solid dispersions | 7 |
| Solubility parameter | 228 |
| Soluplus® | 486 |
| Spectrophotometric | 679 |
| Spheroid | 265 |
| Spray drying | 27 |
| Spray formulation | 271 |
| Stability studies | 141 |
| Staphylococcus aureus | 190 |
| StarLac® | 367 |
| Stem cell | 265 |
| Streptomycin sulfate | 254 |
| Subacute toxicity | 432 |
| Sucrose | 555 |
| Sulconazole nitrate | 259 |
| Sunscreen | 285 |
| Surface solid dispersion | 203 |
| Sustained release tablet | 221 |
| Swab | 182 |
| Swertiamarin | 593 |
| Synbiotic | 293 |
| Synergistic effect | 511, 667 |
| Synthesis | 500 |
| Synthetic cathinones | 235 |
| T-maze | 555 |
| T47D | 280 |
| Tablet | 367 |
| Tableting | 249 |
| Taurine | 659 |
| Telmisartan | 492 |
| Teneligliptin | 141 |
| Theranostic nanomedicine | 381 |
| Therapeutic plasma exchange | 463 |
| Thiocolchicoside | 372 |
| Thiolactomycin | 565 |
| Tobacco smoking | 94 |
| Topical antifungal | 43 |
| Tramadol | 586 |
| Treatment | 576 |
| Trifluralin | 631 |
| Tualang honey | 555, 620 |
| Turkey | 211 |
| Turkish | 653 |
| Tyrosinase | 528 |
| Tyrosine kinase | 424 |
| UV filter | 285 |
| Validation | 74, 56, 141, 182, 593, 679 |
| Vanillic acid | 432 |
| VEGF | 424 |
| Verapamil HCl | 673 |
| Verbascum exuberans Hub.-Mor. | 586 |
| Voltammetry | 398 |
| Wound healing | 271, 610 |
| Wrestler | 172 |
| Xanthan gum | 7 |
| Zero order kinetics | 221 |
| β-sitosterol | 329 |